These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25314033)

  • 21. Efficacy of Topical Use Crisaborole 2% Ointment for Treatment of Necrobiotic Xanthogranuloma Associated With Multiple Myeloma.
    Henning C; Meyers S; Swift R; Eades B; Bussell L; Spektor TM; Berenson JR
    Clin Lymphoma Myeloma Leuk; 2020 Aug; 20(8):e492-e495. PubMed ID: 32389673
    [No Abstract]   [Full Text] [Related]  

  • 22. Cutaneous vasculitis with partial C4 deficiency responsive to dapsone.
    Lilic D; Carmichael AJ
    Br J Dermatol; 1997 Sep; 137(3):476. PubMed ID: 9349359
    [No Abstract]   [Full Text] [Related]  

  • 23. Periocular Necrobiotic Xanthogranuloma Response to Cladribine.
    Agrawal S; Pushker N; Modaboyina S; Das D
    Ophthalmic Plast Reconstr Surg; 2022 Mar-Apr 01; 38(2):e64. PubMed ID: 34314397
    [No Abstract]   [Full Text] [Related]  

  • 24. Necrobiotic Xanthogranuloma.
    Portuguese AJ; Long TH; Linenberger M
    Mayo Clin Proc; 2021 Sep; 96(9):2432-2434. PubMed ID: 34481598
    [No Abstract]   [Full Text] [Related]  

  • 25. Necrobiotic xanthogranuloma with giant cell hepatitis, successfully treated with intravenous immunoglobulins.
    Pedrosa AF; Ferreira O; Calistru A; Mota A; Baudrier T; Sarmento JA; Bettencourt H; Azevedo F
    Dermatol Ther; 2015; 28(2):68-70. PubMed ID: 25650024
    [No Abstract]   [Full Text] [Related]  

  • 26. Necrobiotic xanthogranuloma associated with smoldering multiple myeloma: satisfactory response to cyclophosphamide, dexamethasone, and thalidomide.
    Mello RB; Vale ECSD
    An Bras Dermatol; 2019 Jul; 94(3):337-340. PubMed ID: 31365665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic therapy of necrobiotic xanthogranuloma: a systematic review.
    Steinhelfer L; Kühnel T; Jägle H; Mayer S; Karrer S; Haubner F; Schreml S
    Orphanet J Rare Dis; 2022 Mar; 17(1):132. PubMed ID: 35331271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case of facial lupus erythematosus profundus with intractable ulceration successfully treated with dapsone.
    Saito A; Okiyama N; Saito K; Tanaka R; Maruyama H; Fujimoto M
    J Dermatol; 2017 May; 44(5):e89-e90. PubMed ID: 28447348
    [No Abstract]   [Full Text] [Related]  

  • 29. Transfer factor for the treatment of necrobiotic xanthogranuloma.
    Tang Z; Ruan J; Cai S
    Dermatol Ther; 2022 Dec; 35(12):e15894. PubMed ID: 36196500
    [No Abstract]   [Full Text] [Related]  

  • 30. Thalidomide for necrobiotic xanthogranuloma.
    Ali FR; Lear JT
    Clin Exp Dermatol; 2022 Apr; 47(4):769-770. PubMed ID: 34856016
    [No Abstract]   [Full Text] [Related]  

  • 31. Prospective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria.
    Engin B; Ozdemir M
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):481-6. PubMed ID: 18081753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Necrobiotic xanthogranuloma without a monoclonal gammopathy.
    Seastrom S; Bookout A; Hogan DJ
    Cutis; 2014 Dec; 94(6):293-6. PubMed ID: 25566570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatobiliary and Pancreatic: Hepatic necrobiotic xanthogranuloma.
    Nguyen BD
    J Gastroenterol Hepatol; 2017 Oct; 32(10):1667. PubMed ID: 28948701
    [No Abstract]   [Full Text] [Related]  

  • 34. [Dapsona syndrome].
    Abad Manteca L; Justo Muradas I; Pérez Castrillón JL
    Rev Clin Esp; 2002 Jul; 202(7):414-5. PubMed ID: 12139834
    [No Abstract]   [Full Text] [Related]  

  • 35. Periorbital necrobiotic xanthogranuloma treated successfully with novel multiple myeloma therapy.
    Ghani S; Al Ustwani O; Khalid B; Bogner P; Grassi M; Powell J; Bhat SA
    Clin Adv Hematol Oncol; 2013 Oct; 11(10):678-80. PubMed ID: 24518382
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of necrobiotic xanthogranuloma with 2-chlorodeoxyadenosine.
    Sutton L; Sutton S; Sutton M
    Skinmed; 2013; 11(2):121-3. PubMed ID: 23745232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Necrobiotic Xanthogranuloma.
    Dellatorre G; Miqueloto JK
    JAMA Dermatol; 2020 Jun; 156(6):696. PubMed ID: 32374351
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and safety of dapsone gel 5% for the treatment of acne vulgaris in adolescents.
    Raimer S; Maloney JM; Bourcier M; Wilson D; Papp K; Siegfried E; Garrett S;
    Cutis; 2008 Feb; 81(2):171-8. PubMed ID: 18441772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vesico-bullous subacute cutaneous lupus erythematosus--an uncommon entity successfully treated with dapsone and hydroxychloroquine.
    Pinto-Almeida T; Sanches M; Alves R; Selores M
    Dermatol Online J; 2012 Aug; 18(8):13. PubMed ID: 22948063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Letter: Necrobiotic xanthogranuloma of extremities in an elderly patient successfully treated with low-dose prednisolone.
    Kawakami Y; Yamamoto T
    Dermatol Online J; 2011 Jun; 17(6):13. PubMed ID: 21696693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.